Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation

English version České info

Natural killer (NK) cells are lymphocytes that play a major role in the elimination of virally-infected cells and tumor cells. NK cells recognize and target abnormal cells through activation of stimulatory receptors such as NKG2D. NKG2D ligands are self-proteins, which are absent or expressed at low levels on healthy cells but are induced upon cellular stress, transformation, or viral infection. The exact molecular mechanisms driving expression of these ligands remain poorly understood. Here we show that murine cytomegalovirus (MCMV) infection activates the phosphatidylinositol-3-kinase (PI3K) pathway and that this activation is required for the induction of the RAE-1 family of mouse NKG2D ligands. Among the multiple PI3K catalytic subunits, inhibition of the p110α catalytic subunit blocks this induction. Similarly, inhibition of p110α PI3K reduces cell surface expression of RAE-1 on transformed cells. Many viruses manipulate the PI3K pathway, and tumors frequently mutate the p110α oncogene. Thus, our findings suggest that dysregulation of the PI3K pathway is an important signal to induce expression of RAE-1, and this may represent a commonality among various types of cellular stresses that result in the induction of NKG2D ligands.

Vyšlo v časopise: Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002265
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002265

Souhrn

Zdroje

1. RauletDHVanceRE 2006 Self-tolerance of natural killer cells. Nat Rev Immunol 6 520 531

2. RauletDHGuerraN 2009 Oncogenic stress sensed by the immune system: Role of natural killer cell receptors. Nat Rev Immunol 9 568 580

3. LodoenMBLanierLL 2006 Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18 391 398

4. RauletDH 2003 Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 781 790

5. GrohVRhinehartRRandolph-HabeckerJToppMSRiddellSR 2001 Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2 255 260

6. DiefenbachAJensenERJamiesonAMRauletDH 2001 Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413 165 171

7. GrohVRhinehartRSecristHBauerSGrabsteinKH 1999 Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 96 6879 6884

8. DiefenbachAJamiesonAMLiuSDShastriNRauletDH 2000 Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1 119 126

9. WelteSASinzgerCLutzSZSingh-JasujaHSampaioKL 2003 Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33 194 203

10. EbiharaTMasudaHAkazawaTShingaiMKikutaH 2007 Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 19 1145 1155

11. SalihHRRammenseeHGSteinleA 2002 Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169 4098 4102

12. JonjicSBabicMPolicBKrmpoticA 2008 Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20 30 38

13. LodoenMOgasawaraKHamermanJAAraseHHouchinsJP 2003 NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197 1245 1253

14. HasanMKrmpoticARuzsicsZBubicILenacT 2005 Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 79 2920 2930

15. KrmpoticAHasanMLoewendorfASauligTHaleniusA 2005 NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201 211 220

16. Van BelleTLvon HerrathMG 2009 The role of the activating receptor NKG2D in autoimmunity. Mol Immunol 47 8/11

17. GrohVBahramSBauerSHermanABeauchampM 1996 Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93 12445 12450

18. GasserSOrsulicSBrownEJRauletDH 2005 The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 1186 1190

19. UnniAMBondarTMedzhitovR 2008 Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. Proc Natl Acad Sci U S A 105 1686 1691

20. Stern-GinossarNGurCBitonMHorwitzEElboimM 2008 Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9 1065 1073

21. NachmaniDStern-GinossarNSaridRMandelboimO 2009 Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5 376 385

22. NiceTJCoscoyLRauletDH 2009 Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J Exp Med 206 287 298

23. CerwenkaABakkerABMcClanahanTWagnerJWuJ 2000 Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 721 727

24. CerwenkaABaronJLLanierLL 2001 Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 98 11521 11526

25. TripathySKSmithHRHolroydEAPingelJTYokoyamaWM 2006 Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol 80 545 550

26. IsaacsonMKJuckemLKComptonT 2008 Virus entry and innate immune activation. Curr Top Microbiol Immunol 325 85 100

27. GibsonW 2008 Structure and formation of the cytomegalovirus virion. Curr Top Microbiol Immunol 325 187 204

28. HuangES 1975 Human cytomegalovirus. IV. specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J Virol 16 1560 1565

29. WardJDavisZDeHartJZimmermanEBosqueA 2009 HIV-1 vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog 5 e1000613

30. RichardJSindhuSPhamTNBelzileJPCohenEA 2010 HIV-1 vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115 1354 1363

31. ShenYHUtamaBWangJRaveendranMSenthilD 2004 Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ Res 94 1310 1317

32. GasparMShenkT 2006 Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103 2821 2826

33. YurochkoAD 2008 Human cytomegalovirus modulation of signal transduction. Curr Top Microbiol Immunol 325 205 220

34. CoorayS 2004 The pivotal role of phosphatidylinositol 3-kinase-akt signal transduction in virus survival. J Gen Virol 85 1065 1076

35. BuchkovichNJYuYZampieriCAAlwineJC 2008 The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-akt-mTOR signalling pathway. Nat Rev Microbiol 6 266 275

36. CullyMYouHLevineAJMakTW 2006 Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6 184 192

37. WalkerEHPacoldMEPerisicOStephensLHawkinsPT 2000 Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6 909 919

38. ZunderERKnightZAHousemanBTApselBShokatKM 2008 Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 alpha. Cancer Cell 14 180 192

39. JohnsonRAWangXMaXLHuongSMHuangES 2001 Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol 75 6022 6032

40. PaezJSellersWR 2003 PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 115 145 167

41. VanhaesebroeckBVogtPKRommelC 2010 PI3K: From the bench to the clinic and back. Curr Top Microbiol Immunol 347 1 19

42. KnightZAGonzalezBFeldmanMEZunderERGoldenbergDD 2006 A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125 733 747

43. SamuelsYWangZBardelliASillimanNPtakJ 2004 High frequency of mutations of the PIK3CA gene in human cancers. Science 304 554

44. BachmanKEArganiPSamuelsYSillimanNPtakJ 2004 The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3 772 775

45. KangSBaderAGVogtPK 2005 Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102 802 807

46. IkenoueTKanaiFHikibaYObataTTanakaY 2005 Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 65 4562 4567

47. SamuelsYDiazLAJrSchmidt-KittlerOCumminsJMDelongL 2005 Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7 561 573

48. HsuKMPrattJRAkersWJAchilefuSIYokoyamaWM 2009 Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol 90 33 43

49. VanceREIsbergRRPortnoyDA 2009 Patterns of pathogenesis: Discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6 10 21

50. EngelmanJA 2009 Targeting PI3K signalling in cancer: Opportunities, challenges and limitations. Nat Rev Cancer 9 550 562

51. SoroceanuLAkhavanACobbsCS 2008 Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455 391 395

52. GingrasACRaughtBSonenbergN 1999 eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68 913 963

53. ZhaoLVogtPK 2008 Class I PI3K in oncogenic cellular transformation. Oncogene 27 5486 5496

54. VogtPKHartJRGymnopoulosMJiangHKangS 2010 Phosphatidylinositol 3-kinase: The oncoprotein. Curr Top Microbiol Immunol 347 79 104

55. OgasawaraKHamermanJAHsinHChikumaSBour-JordanH 2003 Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18 41 51

56. JarousseNCoscoyL 2008 Selection of mutant CHO clones resistant to murine gammaherpesvirus 68 infection. Virology 373 376 386